Inventor · disambiguated record
Hamed Aissaoui
Also filed as: AISSAOUI HAMED
38 granted patents·19 pending applications·242 citations·filing 2001–2021
97Inventor score
Files withAISSAOUI HAMED30ACTELION PHARMACEUTICALS LTD19IDORSIA PHARMACEUTICALS LTD6ACTELION PHAMACEUTICALS LTD1
Top patents by PatentIndex Score
57 records- 0194US7763638B2Substituted 1,2,3,4-tetrahydroisoquinoline derivativesACTELION PHARMACEUTICALS LTD·Filed 2005·Granted Jul 27, 2010·24 cites·6 claims
- 0292US7994336B2Azetidine compounds as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Aug 9, 2011·23 cites·15 claims
- 0389US8288429B22-aza-bicyclo[3.3.0]octane derivativesAISSAOUI HAMED·Filed 2008·Granted Oct 16, 2012·15 cites·13 claims
- 0489US8288411B2Pyrrolidines and piperidines as orexin receptor antagonistsAISSAOUI HAMED·Filed 2008·Granted Oct 16, 2012·14 cites·11 claims
- 0588US8236964B2Thiazolidine derivatives as orexin receptor antagonistsAISSAOUI HAMED·Filed 2008·Granted Aug 7, 2012·13 cites·17 claims
- 0688US8106215B23-aza-bicyclo[3.3.0]octane compoundsAISSAOUI HAMED·Filed 2008·Granted Jan 31, 2012·13 cites·15 claims
- 0788US7435815B2Sulfonylamino-acetic acid derivativesACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Oct 14, 2008·10 cites·14 claims
- 0887US8063099B2Trans-3-aza-bicyclo[3.1.0]hexane derivativesAISSAOUI HAMED·Filed 2008·Granted Nov 22, 2011·7 cites·17 claims
- 0986US8288435B22-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonistsAISSAOUI HAMED·Filed 2007·Granted Oct 16, 2012·11 cites·20 claims
- 1086US7834028B2Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Nov 16, 2010·9 cites·19 claims
- 1184US8003654B2N-glycinsulfonamide derivatives and uses as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Aug 23, 2011·7 cites·12 claims
- 1282US8236801B22-aza-bicyclo[2.2.1]heptane derivativesAISSAOUI HAMED·Filed 2009·Granted Aug 7, 2012·6 cites·22 claims
- 1382US6703392B21,2,3,4-tetrahydroisoquinoline derivativesACTELION PHARMACEUTICALS LTD·Filed 2001·Granted Mar 9, 2004·20 cites·22 claims
- 1480US8697869B23-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulatorsAISSAOUI HAMED·Filed 2011·Granted Apr 15, 2014·6 cites·25 claims
- 1580US8133901B23-heteroaryl (amino or amido)-1-(biphenyl or phenylthiazolyl) carbonylpiperidine derivatives as orexin receptor inhibitorsAISSAOUI HAMED·Filed 2007·Granted Mar 13, 2012·4 cites·10 claims
- 1680US7192950B2Benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2001·Granted Mar 20, 2007·15 cites·5 claims
- 1779US8188082B25,6,7,8-tetrahydro-imidazo[1,5-α]pyrazine derivativesAISSAOUI HAMED·Filed 2007·Granted May 29, 2012·8 cites·11 claims
- 1879US7279578B2Sulfonylamino-acetic acid derivativesACTELION PHARMACEUTICALS LTD·Filed 2003·Granted Oct 9, 2007·11 cites·14 claims
- 1976US9879006B2Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Jan 30, 2018·2 cites·29 claims
- 2075US9242970B2Lactam derivatives useful as orexin receptor antagonistsAISSAOUI HAMED·Filed 2011·Granted Jan 26, 2016·3 cites·12 claims
- 2175US9096595B27-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin D2 receptor modulatorsAISSAOUI HAMED·Filed 2012·Granted Aug 4, 2015·4 cites·18 claims
- 2274US7538109B2Quinoxalin-3-one derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2004·Granted May 26, 2009·7 cites·6 claims
- 2372US8889688B2Piperazines as antimalarial agentsAISSAOUI HAMED·Filed 2011·Granted Nov 18, 2014·2 cites·36 claims
- 2470US8575158B21-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulatorsAISSAOUI HAMED·Filed 2011·Granted Nov 5, 2013·2 cites·16 claims
- 2567US8329706B2Oxazolidinone derivativesAISSAOUI HAMED·Filed 2010·Granted Dec 11, 2012·1 cites·15 claims
- 2666US9850241B2Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Dec 26, 2017·1 cites·12 claims
- 2766US6815451B21,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2002·Granted Nov 9, 2004·2 cites·18 claims
- 2866US2021395238A1Nadph oxidase 4 inhibitorsACTELION PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 2964US7375227B2Quinoline derivativesACTELION PHARMACEUTICALS LTD·Filed 2002·Granted May 20, 2008·2 cites·23 claims
- 3063US11136317B2NADPH oxidase 4 inhibitorsACTELION PHARMACEUTICALS LTD·Filed 2020·Granted Oct 5, 2021·0 cites·15 claims
- 3155US11306078B2Piperidine CXCR7 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2020·Granted Apr 19, 2022·0 cites·29 claims
- 3255US2011105514A15,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compoundsAISSAOUI HAMED·Filed 2009·Application pending·0 cites
- 3355US2011224210A1Novel bis-amides as anti-malarial agentsAISSAOUI HAMED·Filed 2009·Application pending·0 cites
- 3454US10301309B2Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted May 28, 2019·0 cites·14 claims
- 3554US2011281869A1Tetrahydroisoquinolines as antimalarial agentsAISSAOUI HAMED·Filed 2009·Application pending·0 cites
- 3654US2011039857A1Piperidine and pyroolidine compoundsAISSAOUI HAMED·Filed 2009·Application pending·0 cites
- 3754US2011105491A1Thiazolidine compounds as orexin receptor antagonistsAISSAOUI HAMED·Filed 2009·Application pending·0 cites
- 3853US2004242564A11,2,3,4-tetrahydroisoquinolines derivativesFiled 2004·Application pending·0 cites
- 3952US2011086889A1Tetrazole compounds as orexin receptor antagonistsAISSAOUI HAMED·Filed 2009·Application pending·0 cites
- 4052US2011212968A1Phenethylamide derivatives and their heterocyclic analoguesAISSAOUI HAMED·Filed 2009·Application pending·0 cites
- 4150US10351560B2Crystalline formsIDORSIA PHARMACEUTICALS LTD·Filed 2016·Granted Jul 16, 2019·0 cites·13 claims
- 4250US2011263662A11,2-diamido-ethylene derivatives as orexin antagonistsAISSAOUI HAMED·Filed 2008·Application pending·0 cites
- 4349US10584118B2NADPH oxidase 4 inhibitorsACTELION PHARMACEUTICALS LTD·Filed 2016·Granted Mar 10, 2020·0 cites·12 claims
- 4449US2010222328A12-cyclopropyl-thiazole derivativesAISSAOUI HAMED·Filed 2008·Application pending·0 cites
- 4548US2010029617A11,4,5,6,7,8-hexahydro-1,2,5-triaza-azulene derivatives as orexin receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 4646US2006178515A1Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonistsAISSAOUI HAMED·Filed 2004·Application pending·0 cites
- 4746US2006211707A1Piperazine-alkyl-ureido derivativesAISSAOUI HAMED·Filed 2004·Application pending·0 cites
- 4846US2010016401A13-aza-bicyclo[3.1.0]hexane derivativesACTELION PHAMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 4946US2007010516A1Novel piperidine derivativesAISSAOUI HAMED·Filed 2004·Application pending·0 cites
- 5045US10752620B2Piperdine CXCR7 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2017·Granted Aug 25, 2020·0 cites·29 claims
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hamed Aissaoui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →